Table 2.
PDE inhibiting activity of selected compounds.
| Cmpd | R1 | R2 | Y | M.W. | cLogPa | tPSAa | G.l. IC50 (nM)b | GlPDE Ki (nM)c | hPDE4B Ki (nM)c |
|---|---|---|---|---|---|---|---|---|---|
| 11 | NO2 | MeO | Y1 | 531.6 | 3.3 | 127.7 | 0.5 ± 0.2 | 500 ± 300 | 0.16 ± 0.02 |
| 18 | NO2 | MeO | Y3 | 479.5 | 2.1 | 127.7 | 0.2 ± 0.1 | >104 | 3.2 ± 0.4 |
| 19 | NO2 | Cl | Y3 | 483.9 | 2.9 | 118.5 | 19.0 ± 3.2 | >106 | 200 ± 50 |
| 20 | H | MeO | Y3 | 434.5 | 2.1 | 84.5 | 930 ± 100 | >106 | 5.0 ± 1.0 |
cLogP, tPSA are calculated using CDD Vault.
mean values ± standard errors are given for quadruplicates, the standard errors correspond to the 95% confidence intervals as calculated via the logit-log algorithm.
mean values ± standard deviations, n ≥ 2.
